New perspectives in nanomedicine

Pharmacology and Therapeutics

Volumn 140, Issue 2, 2013, Pages 176-185

  Thorley, Andrew J ^a   Tetley, Teresa D ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cancer; Carbon nanotubes; Lung; Nanoparticles; Nanotoxicology; Silver

Indexed keywords

BCG VACCINE; CARBON NANOTUBE; CARBOPLATIN; CARBOXYMETHYLCELLULOSE; CHOLESTEROL; CISPLATIN; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; EXCIPIENT; GELATIN; GOLD NANOPARTICLE; INSULIN; ISONIAZID; LIPOSOME; METAL NANOPARTICLE; METHOTREXATE; NANOPARTICLE; NANOSPHERE; PACLITAXEL; POLYPROPYLENE; PYRAZINAMIDE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIFAMPICIN; SALBUTAMOL; SILVER NANOPARTICLE; STEROID; SUBUNIT VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIMICROBIAL THERAPY; ASTHMA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CARDIOTOXICITY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOTOXICITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXPOSURE; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRY POWDER INHALER; GENOTOXICITY; IMMUNOPOTENTIATION; INSULIN TREATMENT; LIPOSOMAL DELIVERY; LONG TERM EXPOSURE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NANOEMULSION; NANOMEDICINE; NANOTOXICOLOGY; NEOPLASM; NEPHROTOXICITY; NONHUMAN; OVARY CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; STOMACH CANCER; SYSTEMIC DISEASE; TESTIS CANCER;

ALVEOLAR TYPE I EPITHELIAL; ALVEOLAR TYPE II EPITHELIAL; ATI; ATII; CANCER; CARBON NANOTUBE; CARBON NANOTUBES; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CNT; COPD; EGF; EPIDERMAL GROWTH FACTOR; LUNG; NANOPARTICLES; NANOTOXICOLOGY; PCL; PEG; PERICILIARY LIQUID; POLYETHYLENE GLYCOL; RESPIRATORY SYNCYTIAL VIRUS; RSV; SILVER; TB; TRANSFORMED TYPE I; TT1; TUBERCULOSIS;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LUNG; LUNG DISEASES; NANOMEDICINE; NEOPLASMS; VACCINES;

EID: 84885190174     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.06.008     Document Type: Review

References (95)

1. J.W. Alexander History of the medical use of silver Surg Infect (Larchmt) 10 2009 289 292
2. A. Antonelli, S. Serafini, M. Menotta, C. Sfara, F. Pierige, and L. Giorgi Improved cellular uptake of functionalized single-walled carbon nanotubes Nanotechnology 21 2010 425101
3. A. Asati, S. Santra, C. Kaittanis, and J.M. Perez Surface-charge- dependent cell localization and cytotoxicity of cerium oxide nanoparticles ACS Nano 4 2010 5321 5331
4. P.V. AshaRani, G. Low Kah Mun, M.P. Hande, and S. Valiyaveettil Cytotoxicity and genotoxicity of silver nanoparticles in human cells ACS Nano 3 2008 279 290
5. H. Ayhan, A. Tuncel, N. Bor, and E. Piskin Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties J Biomater Sci Polym Ed 7 1995 329 342
6. M.M. Bailey, E.M. Gorman, E.J. Munson, and C. Berkland Pure insulin nanoparticle agglomerates for pulmonary delivery Langmuir 24 2008 13614 13620
7. M. Ballester, C. Nembrini, N. Dhar, A. de Titta, C. de Piano, and M. Pasquier Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis Vaccine 29 2011 6959 6966
8. A. Bandyopadhyay, and S. Raghavan Defining the role of integrin alphavbeta6 in cancer Curr Drug Targets 10 2009 645 652
9. P.J. Barnes New therapies for chronic obstructive pulmonary disease Med Princ Pract 19 2010 330 338
10. M.R. Becklake, E. Bagatin, and J.A. Neder Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century Int J Tuberc Lung Dis 11 2007 356 369
11. Bhavna, F.J. Ahmad, G. Mittal, G.K. Jain, G. Malhotra, and R.K. Khar Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions Eur J Pharm Biopharm 71 2009 282 291
12. A.A. Bhirde, V. Patel, J. Gavard, G. Zhang, A.A. Sousa, and A. Masedunskas Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery ACS Nano 3 2009 307 316
13. A.A. Bhirde, S. Patel, A.A. Sousa, V. Patel, A.A. Molinolo, and Y. Ji Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice Nanomedicine 5 2010 1535 1546
14. B. Button, L.H. Cai, C. Ehre, M. Kesimer, D.B. Hill, and J.K. Sheehan A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia Science 337 2012 937 941
15. J.A. Champion, A. Walker, and S. Mitragotri Role of particle size in phagocytosis of polymeric microspheres Pharm Res 25 2008 1815 1821
16. Y. Chen, V.J. Mohanraj, F. Wang, and H.A. Benson Designing chitosan-dextran sulfate nanoparticles using charge ratios AAPS PharmSciTech 8 2007 131 139
17. Y.H. Chen, C.Y. Tsai, P.Y. Huang, M.Y. Chang, P.C. Cheng, and C.H. Chou Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model Mol Pharm 4 2007 713 722
18. L. Chen, H. Xie, and Y. Wei Functionalization Methods of Carbon Nanotubes and Its Applications J.M. Marulanda, Carbon nanotubes applications on electron devices 2011 InTech Shanghai 213 232
19. H.S. Choi, Y. Ashitate, J.H. Lee, S.H. Kim, A. Matsui, and N. Insin Rapid translocation of nanoparticles from the lung airspaces to the body Nat Biotechnol 28 2010 1300 1303
20. 4) expression in human lung cancer as monitored by specific monoclonal antibodies Cancer Res 50 1990 6107 6112
21. 1 antagonist targets stealth liposomes to integrin-overexpressing melanoma Nanomedicine 8 2012 1152 1161
22. S.R. Datir, M. Das, R.P. Singh, and S. Jain Hyaluronate tethered, smart multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin Bioconjug Chem 23 11 2012 2201 2213
23. M.J. Ernsting, M. Murakami, E. Undzys, A. Aman, B. Press, and S.D. Li A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases J Control Release 162 2012 575 581
24. J. Ferin, and G. Oberdorster Translocation of particles from pulmonary alveoli into the interstitium J Aerosol Med 5 1992 179 187
25. R. Foldbjerg, E.S. Irving, Y. Hayashi, D.S. Sutherland, K. Thorsen, and H. Autrup Global gene expression profiling of human lung epithelial cells after exposure to nanosilver Toxicol Sci 130 2012 145 157
26. J. Fong, and F. Wood Nanocrystalline silver dressings in wound management: a review Int J Nanomedicine 1 2006 441 449
27. M. Gasser, P. Wick, M.J. Clift, F. Blank, L. Diener, and B. Yan Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro Part Fibre Toxicol 9 2012 17
28. M. Geiser, N. Leupin, I. Maye, V.I. Hof, and P. Gehr Interaction of fungal spores with the lungs: distribution and retention of inhaled puffball (Calvatia excipuliformis) spores J Allergy Clin Immunol 106 2000 92 100
29. M. Geiser, S. Schurch, and P. Gehr Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer J Appl Physiol 94 2003 1793 1801
30. W.J. Gradishar, S. Tjulandin, N. Davidson, H. Shaw, N. Desai, and P. Bhar Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J Clin Oncol 23 2005 7794 7803
31. C.B. Hall, G.A. Weinberg, M.K. Iwane, A.K. Blumkin, K.M. Edwards, and M.A. Staat The burden of respiratory syncytial virus infection in young children N Engl J Med 360 2009 588 598
32. H. Hashizume, P. Baluk, S. Morikawa, J.W. McLean, G. Thurston, and S. Roberge Openings between defective endothelial cells explain tumor vessel leakiness Am J Pathol 156 2000 1363 1380
33. Y. Huang, X. Li, Z. Liao, G. Zhang, Q. Liu, and J. Tang A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis Burns 33 2007 161 166
34. ICRP Human respiratory tract model for radiological protection Ann ICRP 24 1994 1 482
35. R.J. Inman, C.F. Snelling, F.J. Roberts, K. Shaw, and J.C. Boyle Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection Burns Incl Therm Inj 11 1984 35 40
36. J.R. Johnson, P.L. Roberts, R.J. Olsen, K.A. Moyer, and W.E. Stamm Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates J Infect Dis 162 1990 1145 1150
37. A. Joshi, R. Keerthiprasad, R.D. Jayant, and R. Srivastava Nano-in-micro alginate based hybrid particles Carbohydr Polym 81 2010 790 798
38. A.A. Kapralov, W.H. Feng, A.A. Amoscato, N. Yanamala, K. Balasubramanian, and D.E. Winnica Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration ACS Nano 6 2012 4147 4156
39. H. Kawaguchi, N. Koiwai, Y. Ohtsuka, M. Miyamoto, and S. Sasakawa Phagocytosis of latex particles by leucocytes. I. Dependence of phagocytosis on the size and surface potential of particles Biomaterials 7 1986 61 66
40. Y. Kawashima, H. Yamamoto, H. Takeuchi, S. Fujioka, and T. Hino Pulmonary delivery of insulin with nebulized dl-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect J Control Release 62 1999 279 287
41. R.S. Kaye, T.S. Purewal, and H.O. Alpar Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies J Pharm Sci 98 2009 4055 4068
42. S.J. Kemp, A.J. Thorley, J. Gorelik, M.J. Seckl, M.J. O'Hare, and A. Arcaro Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake Am J Respir Cell Mol Biol 39 2008 591 597
43. M. Kendall, P. Ding, R.M. Mackay, R. Deb, Z. McKenzie, and K. Kendall Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles Nanotoxicology 1-11 2012
44. M. Kendall, J. Guntern, N.P. Lockyer, F.H. Jones, B.M. Hutton, and M. Lippman Urban PM2.5 surface chemistry and interactions with bronchoalveolar lavage fluid Inhal Toxicol 16 2004 115 129
45. M.R. Knowles, and R.C. Boucher Mucus clearance as a primary innate defense mechanism for mammalian airways J Clin Invest 109 2002 571 577
46. S. Kraszewski, A. Bianco, M. Tarek, and C. Ramseyer Insertion of short amino-functionalized single-walled carbon nanotubes into phospholipid bilayer occurs by passive diffusion PLoS One 7 2012 e40703
47. S.K. Lai, Y.Y. Wang, and J. Hanes Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv Drug Deliv Rev 61 2009 158 171
48. H.H. Lara, E.N. Garza-Trevino, L. Ixtepan-Turrent, and D.K. Singh Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds J Nanobiotechnol 9 2011 30
49. S.K. Libutti, G.F. Paciotti, A.A. Byrnes, H.R. Alexander, W.E. Gannon, and M. Walker Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine Clin Cancer Res 16 2010 6139 6149
50. R.T. Lin, K. Takahashi, A. Karjalainen, T. Hoshuyama, D. Wilson, and T. Kameda Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis Lancet 369 2007 844 849
51. D.M. Lindell, S.B. Morris, M.P. White, L.E. Kallal, P.K. Lundy, and T. Hamouda A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease PLoS One 6 2011 e21823
52. J. Lipka, M. Semmler-Behnke, R.A. Sperling, A. Wenk, S. Takenaka, and C. Schleh Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection Biomaterials 31 2010 6574 6581
53. J. Liu, T. Gong, H. Fu, C. Wang, X. Wang, and Q. Chen Solid lipid nanoparticles for pulmonary delivery of insulin Int J Pharm 356 2008 333 344
54. W. Liu, Y. Wu, C. Wang, H.C. Li, T. Wang, and C.Y. Liao Impact of silver nanoparticles on human cells: effect of particle size Nanotoxicology 4 2010 319 330
55. Y.A. Luqmani Mechanisms of drug resistance in cancer chemotherapy Med Princ Pract 14 Suppl. 1 2005 35 48
56. L. Ma-Hock, S. Treumann, V. Strauss, S. Brill, F. Luizi, and M. Mertler Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months Toxicol Sci 112 2009 468 481
57. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs Cancer Res 46 1986 6387 6392
58. R.L. Maynard, K. Donaldson, and T.D. Tetley Type 1 pulmonary epithelial cells: a new compartment involved in the slow phase of particle clearance from alveoli Nanotoxicology 1-2 2012
59. S.M. Mijailovich, M. Kojic, and A. Tsuda Particle-induced indentation of the alveolar epithelium caused by surface tension forces J Appl Physiol 109 2010 1179 1194
60. F.A. Murphy, C.A. Poland, R. Duffin, K.T. Al-Jamal, H. Ali-Boucetta, and A. Nunes Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura Am J Pathol 178 2011 2587 2600
61. A. Nagy, A. Steinbrck, J. Gao, N. Doggett, J.A. Hollingsworth, and R. Iyer Comprehensive analysis of the effects of CdSe quantum dot size, surface charge, and functionalization on primary human lung cells ACS Nano 6 2012 4748 4762
62. J.J. Neumiller, and R.K. Campbell Technosphere insulin: an inhaled prandial insulin product BioDrugs 24 2010 165 172
63. R. Pandey, A. Sharma, A. Zahoor, S. Sharma, G.K. Khuller, and B. Prasad Poly (dl-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis J Antimicrob Chemother 52 2003 981 986
64. E.J. Park, K. Choi, and K. Park Induction of inflammatory responses and gene expression by intratracheal instillation of silver nanoparticles in mice Arch Pharm Res 34 2011 299 307
65. J. Pauluhn Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures Toxicol Sci 113 2010 226 242
66. A. Persidis Cancer multidrug resistance Nat Biotechnol 17 1999 94 95
67. C.A. Poland, R. Duffin, I. Kinloch, A. Maynard, W.A. Wallace, and A. Seaton Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study Nat Nanotechnol 3 2008 423 428
68. C.A. Pope III, R.T. Burnett, M.J. Thun, E.E. Calle, D. Krewski, and K. Ito Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution JAMA 287 2002 1132 1141
69. P. Ruenraroengsak, P. Novak, D. Berhanu, A.J. Thorley, E. Valsami-Jones, and J. Gorelik Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles Nanotoxicology 6 2012 94 108
70. C.A. Ruge, J. Kirch, O. Cadas, M. Schneider, J. Perez-Gil, and U.F. Schaefer Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A Nanomedicine 7 2011 690 693
71. C.A. Ruge, U.F. Schaefer, J. Herrmann, J. Kirch, O. Cañadas, and M. Echaide The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles PLoS One 7 2012 e40775
72. V. Rusch, D. Klimstra, E. Venkatraman, P.W. Pisters, J. Langenfeld, and E. Dmitrovsky Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression Clin Cancer Res 3 1997 515 522
73. Y. Sakamoto, D. Nakae, N. Fukumori, K. Tayama, A. Maekawa, and K. Imai Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats J Toxicol Sci 34 2009 65 76
74. J.M. Samet, F. Dominici, F.C. Curriero, I. Coursac, and S.L. Zeger Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994 N Engl J Med 343 2000 1742 1749
75. R.K. Saxena, W. Williams, J.K. Mcgee, M.J. Daniels, E. Boykin, and M. Ian Gilmour Enhanced in vitro and in vivo toxicity of poly-dispersed acid-functionalized single-wall carbon nanotubes Nanotoxicology 1 2007 291 300
76. C. Schleh, U. Holzwarth, S. Hirn, A. Wenk, F. Simonelli, and M. Schaffler Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D J Aerosol Med Pulm Drug Deliv 26 1 2013 24 30
77. P. Sengupta, S. Basu, S. Soni, A. Pandey, B. Roy, and M.S. Oh Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity Proc Natl Acad Sci 109 2012 11294 11299
78. A.A. Shvedova, E.R. Kisin, R. Mercer, A.R. Murray, V.J. Johnson, and A.I. Potapovich Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice Am J Physiol Lung Cell Mol Physiol 289 2005 L698 L708
79. N. Sigurs, R. Bjarnason, F. Sigurbergsson, and B. Kjellman Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7 Am J Respir Crit Care Med 161 2000 1501 1507
80. M.B. Sikkel, J.K. Quint, P. Mallia, J.A. Wedzicha, and S.L. Johnston Respiratory syncytial virus persistence in chronic obstructive pulmonary disease Pediatr Infect Dis J 27 2008 S63 S70
81. Y. Song, W. Namkung, D.W. Nielson, J.W. Lee, W.E. Finkbeiner, and A.S. Verkman Airway surface liquid depth measured in ex vivo fragments of pig and human trachea: dependence on Na+ and Cl- channel function Am J Physiol Lung Cell Mol Physiol 297 2009 L1131 L1140
82. K.S. Song, J.H. Sung, J.H. Ji, J.H. Lee, J.S. Lee, and H.R. Ryu Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats Nanotoxicology 1-12 2012
83. A. Sosnik, M. Carcaboso, R.J. Glisoni, M.A. Moretton, and D.A. Chiappetta New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery Adv Drug Deliv Rev 62 2010 547 559
84. L.C. Stoehr, E. Gonzalez, A. Stampfl, E. Casals, A. Duschl, and V. Puntes Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells Part Fibre Toxicol 8 2011 36
85. J.S. Suk, S.K. Lai, N.J. Boylan, M.R. Dawson, M.P. Boyle, and J. Hanes Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine Nanomedicine 6 2011 365 375
86. J.H. Sung, J.H. Ji, J.U. Yoon, D.S. Kim, M.Y. Song, and J. Jeong Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles Inhal Toxicol 20 2008 567 574
87. S. Takenaka, E. Karg, W.G. Kreyling, B. Lentner, W. M + Âller, and M. Behnke-Semmler Distribution pattern of inhaled ultrafine gold particles in the rat lung Inhal Toxicol 18 2006 733 740
88. The Project on Emerging Nanotechnologies: Consumer Product Inventory. (2008). The Woodrow Wilson International Center for Scholars.
89. A.J. Thorley, D. Grandolfo, E. Lim, P. Goldstraw, A. Young, and T.D. Tetley Innate immune responses to bacterial ligands in the peripheral human lung - role of alveolar epithelial TLR expression and signalling PLoS One 6 2011 e21827
90. H. Tong, J.K. Mcgee, R.K. Saxena, U.P. Kodavanti, R.B. Devlin, and M.I. Gilmour Influence of acid functionalization on the cardiopulmonary toxicity of carbon nanotubes and carbon black particles in mice Toxicol Appl Pharmacol 239 2009 224 232
91. C.L. Tseng, W.Y. Su, K.C. Yen, K.C. Yang, and F.H. Lin The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation Biomaterials 30 2009 3476 3485
92. 2-agonist particle size Am J Respir Crit Care Med 172 2005 1497 1504
93. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D.A. Berk, and V.P. Torchilin Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res 55 1995 3752 3756
94. Q. Zhang, Z. Shen, and T. Nagai Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats Int J Pharm 218 2001 75 80
95. Y.Z. Zhao, X. Li, C.T. Lu, Y.Y. Xu, H.F. Lv, and D.D. Dai Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy Acta Diabetol 49 2012 315 325